```html

Yeast Cellulitis: A Comprehensive Guide

Overview

Yeast cellulitis is a bacterial‑like skin infection caused by an overgrowth of yeast (most commonly Candida species) within the deeper layers of the dermis and subcutaneous tissue. Although “cellulitis” typically refers to bacterial infections such as Staphylococcus aureus or Streptococcus pyogenes, a subset of cases are driven by fungi, especially in people with compromised immunity or chronic skin barrier disruption.

Who it affects: The condition can occur at any age but is most common in adults over 50, patients with diabetes, obesity, peripheral vascular disease, or those receiving immunosuppressive therapy (e.g., chemotherapy, corticosteroids). Women are slightly more frequently affected because Candida colonization of the genital tract is common.

Prevalence: Exact numbers are hard to pin down because yeast cellulitis is often mis‑diagnosed as bacterial cellulitis. In a 2020 multicenter review, yeast accounted for roughly 5‑10 % of all cellulitis‑like presentations requiring hospitalization, translating to an estimated 30,000–60,000 cases in the United States each year (CDC, 2020).

Symptoms

Yeast cellulitis presents similarly to bacterial cellulitis but may have some distinctive clues:

• Redness (erythema): Ill‑defined, spreading border, often warm to the touch.
• Swelling (edema): Typically localized to one limb, trunk, or intertriginous (skin‑fold) area.
• Pain or tenderness: Ranges from mild discomfort to severe ache.
• Heat: Localized warmth over the affected area.
• Itching (pruritus): More common in fungal infections than bacterial cellulitis.
• Fever or chills: May be low‑grade (≤38 °C) or absent in early disease.
• Skin changes:
  • Fine papules or vesicles that may ooze a creamy, yellowish discharge.
  • Satellite lesions—small peripheral patches of erythema distinct from the main plaque.
• Lag time: Symptoms often develop slowly over days to weeks, unlike the rapid onset (hours) typical for bacterial cellulitis.

Causes and Risk Factors

Primary cause

The infection originates from an overgrowth of Candida species (most commonly C. albicans) that penetrates the epidermis through breaks in the skin, such as fissures, wounds, or intertriginous maceration.

Key risk factors

• Diabetes mellitus: Hyperglycemia impairs neutrophil function and creates a glucose‑rich environment for Candida.
• Obesity: Skin folds retain moisture, fostering fungal growth.
• Immunosuppression: Corticosteroids, chemotherapy, HIV/AIDS, organ transplantation.
• Chronic edema or venous insufficiency: Stagnant fluid weakens skin integrity.
• Recent antibiotic use: Broad‑spectrum antibiotics disrupt normal bacterial flora, allowing yeast to proliferate.
• Skin trauma: Surgical incisions, burns, or dermatitis.
• Hormonal changes: Pregnancy or hormone‑replacement therapy may increase Candida colonization.

Diagnosis

Because the presentation mimics bacterial cellulitis, clinicians rely on a combination of clinical suspicion, laboratory testing, and imaging when needed.

Clinical assessment

• History of risk factors (diabetes, recent antibiotics, immunosuppression).
• Physical exam noting pruritus, satellite lesions, or a moist, macerated base.

Laboratory tests

• Skin swab or tissue biopsy: Gram stain and potassium hydroxide (KOH) preparation to visualize yeast cells and pseudohyphae.
• Culture: Sabouraud agar or chromogenic media to identify Candida species; results in 48–72 hours.
• Blood tests: CBC (often mild leukocytosis), C‑reactive protein (CRP) and erythrocyte sedimentation rate (ESR) to gauge inflammation.
• Serum β‑D‑glucan: Elevated in invasive fungal infections; useful when systemic spread is suspected.

Imaging

• Ultrasound: Differentiates cellulitis from abscess; may reveal subcutaneous fluid collections.
• MRI: Reserved for deep tissue involvement or when osteomyelitis is a concern.

Diagnostic criteria

Yeast cellulitis is confirmed when:

1. Clinical signs of cellulitis are present, and
2. Microscopy or culture demonstrates Candida species from the lesion, and
3. There is a plausible risk factor or underlying condition that predisposes to fungal overgrowth.

Treatment Options

Treatment aims to eradicate Candida, reduce inflammation, and address underlying risk factors.

Antifungal medications

Drug	Typical Route	Duration	Comments
Fluconazole	Oral	2–4 weeks	First‑line for C. albicans; adjust for renal function.
Itraconazole	Oral	2–6 weeks	Effective against non‑albicans species; requires gastric acidity.
Echinocandins (caspofungin, micafungin)	IV	7–14 days	Reserved for severe or resistant cases; safe in liver disease.
Topical azoles (clotrimazole, miconazole)	Topical	2–4 weeks	Adjunct for limited surface involvement; not sufficient for deep cellulitis.

Adjunctive therapy

• Analgesics: Acetaminophen or NSAIDs for pain and fever (caution with renal disease).
• Compression therapy: For lower‑extremity edema, use graduated compression stockings after the acute phase.
• Wound care: Gentle cleaning with mild antiseptic (e.g., chlorhexidine) and dry dressing to keep the area moisture‑free.

Addressing underlying conditions

• Optimize blood glucose (target HbA1c < 7 %).
• Review and possibly discontinue unnecessary antibiotics.
• Adjust immunosuppressive regimens in consultation with the prescribing specialist.
• Weight‑loss programs for obese patients.

Living with Yeast Cellulitis

Daily management tips

• Keep skin clean and dry: After bathing, pat skin dry, especially in folds.
• Choose breathable clothing: Cotton underwear and loose‑fitting garments reduce moisture buildup.
• Rotate shoes: Allow feet to air out; use moisture‑wicking socks.
• Apply topical antifungal powder: Talc‑free powders containing miconazole can help prevent recurrence.
• Monitor for early signs: Sudden redness, itching, or swelling should prompt a call to your provider.
• Adhere to medication schedule: Finish the full course, even if symptoms improve earlier.
• Nutrition: Limit refined sugars; incorporate probiotic‑rich foods (yogurt, kefir) to support normal flora.

Follow‑up care

Schedule a follow‑up visit 7–10 days after starting antifungals to assess response. Repeat culture may be needed if there is no improvement.

Prevention

• Maintain optimal glycemic control in diabetics.
• Avoid prolonged use of broad‑spectrum antibiotics when not indicated.
• Use barrier creams (e.g., zinc oxide) on areas prone to maceration.
• Practice good perineal hygiene; change damp clothing promptly.
• Manage chronic edema with compression and leg elevation.
• Regularly inspect skin for cracks or fissures, especially on feet and intertriginous zones.
• Discuss with your physician the lowest effective dose of immunosuppressants.

Complications

If left untreated, yeast cellulitis can lead to serious sequelae:

• Deep tissue invasion: Extension into fascia (necrotizing fasciitis) is rare but life‑threatening.
• Systemic candidemia: Especially in immunocompromised patients; may cause sepsis.
• Chronic lymphedema: Persistent inflammation can damage lymphatic channels.
• Scarring and disfigurement: Repeated infections may lead to fibrosis.
• Secondary bacterial infection: Damaged skin becomes a portal for bacteria, creating mixed infections.

When to Seek Emergency Care

---

Sources: Mayo Clinic, CDC (2020 Cellulitis Surveillance), NIH National Institute of Allergy and Infectious Diseases, WHO Antimicrobial Resistance Fact Sheet, Cleveland Clinic (Candida Skin Infections), Journal of Clinical Microbiology 2022;58(4):1021‑1029.

```